Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function
Proceedings of the National Academy of Sciences · 2024
DOI: 10.1073/pnas.2412690121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Martin Schlegel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, Technical University of Munich, Klinikum rechts der Isar, Technical University of Munich (T…. Hauptthemen laut MEDLINE: Atherosclerosis, Macrophages, Netrin Receptors, Plaque, Atherosclerotic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, American Heart Association (AHA), HHS | NIH | NHLBI | Division of Intramural Research (DIR).
Abstract (Originalsprache)
Atherosclerosis results from lipid-driven inflammation of the arterial wall that fails to resolve. Imbalances in macrophage accumulation and function, including diminished migratory capacity and defective efferocytosis, fuel maladaptive inflammation and plaque progression. The neuroimmune guidance cue netrin-1 has dichotomous roles in inflammation partly due to its multiple receptors; in atherosclerosis, netrin-1 promotes macrophage survival and retention via its receptor Unc5b. To minimize the pleiotropic effects of targeting netrin-1, we tested the therapeutic potential of deleting Unc5b in mice with advanced atherosclerosis. We generated Unc5b fl/fl Cx3cr1 creERT2/WT mice, which allowed conditional deletion of Un5b (∆ Unc5b MØ ) in monocytes and macrophages by tamoxifen injection. After inducing advanced atherosclerosis by hepatic PCSK9 overexpression and western diet feeding for 20 wk, Unc5b was deleted and hypercholesterolemia was normalized to simulate clinical lipid management. Deletion of myeloid Unc5b led to a 40% decrease in atherosclerotic plaque burden and reduced plaque complexity compared to Unc5b fl/fl Cx3cr1 WT/WT littermate controls (Ctrl MØ ). Consistently, plaque macrophage content was reduced by 50% in ∆ Unc5b MØ mice due to reduced plaque Ly6C hi monocyte recruitment and macrophage retention. Compared to Ctrl MØ mice, plaques in ∆ Unc5b MØ mice had reduced necrotic area and fewer apoptotic cells, which correlated with improved efferocytotic capacity by Unc5b -deficient macrophages in vivo and in vitro. Beneficial changes in macrophage dynamics in the plaque upon Unc5b deletion were accompanied by an increase in atheroprotective T cell populations, including T-regulatory and Th2 cells. Our data identify Unc5b in advanced atherosclerosis as a therapeutic target to induce pro-resolving restructuring of the plaque immune cells and to promote atherosclerosis regression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Intensive Care Medicine, Technical University of Munich, Klinikum rechts der Isar, Technical University of Munich (TUM) School of Medicine and Health, Munich 81675, Germany.
- Department of Medicine, Cardiovascular Research Center, New York University Grossman School of Medicine, New York, NY 10016.
- Department of Cell Biology, New York University Langone Health, New York, NY 10016.
ORCID-Profile: Yannick Cyr, Alexandra A C Newman, Fazli K Bozal, Coen van Solingen, Edward A Fisher, Kathryn J Moore
Förderung
- NHLBI NIH HHS
- American Heart Association (AHA)
- HHS | NIH | NHLBI | Division of Intramural Research (DIR)
- Canadian Government | Canadian Institutes of Health Research (CIHR)
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
Zitieren
APA
Schlegel, M., Cyr, Y., Newman, A. A. C., Schreyer, K., Barcia Durán, J. G., Sharma, M., Bozal, F. K., Gourvest, M., La Forest, M., Afonso, M. S., van Solingen, C., Fisher, E. A., & Moore, K. J. (2024). Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2412690121
Vancouver
Schlegel M, Cyr Y, Newman AAC, Schreyer K, Barcia Durán JG, Sharma M, et al. Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2412690121
BibTeX
@article{Schlegel2024,
author = {Schlegel, Martin and Cyr, Yannick and Newman, Alexandra A C and Schreyer, Korbinian and Barcia Durán, José Gabriel and Sharma, Monika and Bozal, Fazli K and Gourvest, Morgane and La Forest, Maxwell and Afonso, Milessa S and van Solingen, Coen and Fisher, Edward A and Moore, Kathryn J},
title = {Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
doi = {10.1073/pnas.2412690121}
}
EUVIMED